Patient profile and periprocedural outcomes of bioresorbable vascular scaffold implantation in comparison with drug-eluting and bare-metal stent implantation. Experience from ORPKI Polish National Registry 2014–2015

@inproceedings{Rzeszutko2016PatientPA,
  title={Patient profile and periprocedural outcomes of bioresorbable vascular scaffold implantation in comparison with drug-eluting and bare-metal stent implantation. Experience from ORPKI Polish National Registry 2014–2015},
  author={Łukasz Rzeszutko and Tomasz A Tokarek and Zbigniew Siudak and Artur Dziewierz and Krzysztof Żmudka and D Dipl-Chem Dr Dudek},
  booktitle={Postepy w kardiologii interwencyjnej = Advances in interventional cardiology},
  year={2016}
}
INTRODUCTION There are limited data on the comparison of bioresorbable vascular scaffold (BVS) and drug-eluting stent (DES)/bare-metal stent (BMS) implantation in an unselected population of patients with coronary artery disease. AIM To compare the periprocedural outcomes and patient profile of BVS and DES/BMS implantation in an all-comer population from the ORPKI Polish National Registry. MATERIAL AND METHODS A total of 141,324 consecutive patients from 151 invasive cardiology centers in… CONTINUE READING
2
Twitter Mentions

Citations

Publications citing this paper.
SHOWING 1-6 OF 6 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 33 REFERENCES

Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.

  • The New England journal of medicine
  • 2015
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Appropriate use of bioresorbable vascular scaffolds in percutaneous coronary interventions: a recommendation from experienced users

Bert R C Everaert, Cordula M Felix, +11 authors Robert-Jan M. van Geuns
  • Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
  • 2015
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…